Mouse Anti-PSMD10 Monoclonal Antibody – Cat# MBS6178528

Detection limit for recombinant GST tagged PSMD10 is 3 ng/ml as a capture antibody.

PSMD10 Antibody – Mouse Monoclonal

Name: PSMD10 Antibody; Monoclonal; Mouse; MyBioSource
Brand: MyBioSource
SKU: MBS6178528
Price: 1140 USD
Availability: InStock
Rating: 5 (10 reviews)

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS6178528

The 26S proteasome is a multicatalytic proteinase complex with a highly ordered structure composed of 2 complexes, a 20S core and a 19S regulator. The 20S core is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2… More details

$1140 / 0.1 mL +1 FREE 8GB USB

Product Documentation

Sample Manual Insert View PDF

Testing Data View PDF

Certificate of Analysis (COA) View PDF

QC Report View PDF

Material Safety Data Sheet View PDF

Technical Datasheet View PDF

Protocol View PDF

Product Overview

Online Datasheet in PDF

Product Name

PSMD10, Monoclonal Antibody

Full Product Name

PSMD10 (Proteasome (Prosome, Macropain) 26S Subunit, non-ATPase, 10, dJ889N15.2, p28) (FITC)

Product Gene Name

anti-PSMD10 antibody

Product Synonym Names

Proteasome (Prosome; Macropain) 26S Subunit; non-ATPase; 10; dJ889N15.2; p28

Clonality

Monoclonal

Isotype

IgG1,k

Clone Number

1B4

Host

Mouse

Form/Format

Supplied as a liquid in PBS, pH 7.2. No preservative added. Labeled with Fluorescein isothiocyanate (FITC).

Purity/Purification

Purified

Specificity

Recognizes PSMD10.

Preparation and Storage

Store product at 4 degree C if to be used immediately within two weeks. For long-term storage, aliquot to avoid repeated freezing and thawing and store at -20 degree C. Aliquots are stable at -20 degree C for 12 months after receipt. Dilute required amount only prior to immediate use. Further dilutions can be made in assay buffer.

FITC conjugates are sensitive to light. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Immunogen

PSMD10 (AAH11960, 127aa-226aa) partial recombinant protein with GST tag. MW of the GST tag alone is 26kD.

Conjugate

FITC

Product Categories/Family for anti-PSMD10 antibody

Antibodies; Proteasomes

Applications Tested/Suitable for anti-PSMD10 antibody

Western Blot (WB)

Application Notes for anti-PSMD10 antibody

Applications are based on unconjugated antibody.

Other Notes

Small volumes of anti-PSMD10 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for PSMD10 purchase

MBS6178528 is an antibody targeting PSMD10. Also known as PSMD10 (Proteasome (Prosome, Macropain) 26S Subunit, non-ATPase, 10, dJ889N15.2, p28) (FITC). Host: Mouse.

Additional Details

NCBI/Uniprot data below describe general gene information for PSMD10. It may not necessarily be applicable to this product.

NCBI GI #

15080417

NCBI GeneID

5716

NCBI Accession #

AAH11960

UniProt Related Accession #

O75832

NCBI Official Full Name

Proteasome (prosome, macropain) 26S subunit, non-ATPase, 10

NCBI Official Synonym Full Names

proteasome 26S subunit, non-ATPase 10

NCBI Official Symbol

PSMD10

NCBI Official Synonym Symbols

p28; p28(GANK); dJ889N15.2

Protein Family

26S proteasome non-ATPase regulatory

NCBI Protein Information

26S proteasome non-ATPase regulatory subunit 10

NCBI Summary for PSMD10

This gene encodes a subunit of the PA700/19S complex, which is the regulatory component of the 26S proteasome. The 26S proteosome complex is required for ubiquitin-dependent protein degradation. This protein is a non-ATPase subunit that may be involved in protein-protein interactions. Aberrant expression of this gene may paly a role in tumorigenesis. Two transcripts encoding different isoforms have been described. Pseudogenes have been identified on chromosomes 3 and 20.[provided by RefSeq, Mar 2011]

Research Articles on PSMD10

1. 38 (72%) colorectal cancer (CRC) patients had increased gankyrin expression in tumor cells. The enhanced gankyrin expression in tumor cells was associated with unfavorable progression-free survival and could serve as a biomarker to predict therapeutic response in patients with metastatic CRC.

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Products associated with anti-PSMD10 antibody

Reference Product	PubMed Publications
PSMC4 antibody	>2 publications with PSMD10 and PSMC4
PSMC1 antibody	>1 publications with PSMD10 and PSMC1

Pathways associated with anti-PSMD10 antibody

Products by Pathway	Pathway Diagram
AMER1 Mutants Destabilize The Destruction Complex Pathway antibodies	AMER1 Mutants Destabilize The Destruction Complex Pathway Diagram
APC Truncation Mutants Are Not K63 Polyubiquitinated Pathway antibodies	APC Truncation Mutants Are Not K63 Polyubiquitinated Pathway Diagram
APC Truncation Mutants Have Impaired AXIN Binding Pathway antibodies	APC Truncation Mutants Have Impaired AXIN Binding Pathway Diagram
APC/C-mediated Degradation Of Cell Cycle Proteins Pathway antibodies	APC/C-mediated Degradation Of Cell Cycle Proteins Pathway Diagram
APC/C:Cdc20 Mediated Degradation Of Securin Pathway antibodies	APC/C:Cdc20 Mediated Degradation Of Securin Pathway Diagram
APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins Pathway antibodies	APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins Pathway Diagram
APC/C:Cdh1 Mediated Degradation Of Cdc20 And Other APC/C:Cdh1 Targeted Proteins In Late Mitosis/early G1 Pathway antibodies	APC/C:Cdh1 Mediated Degradation Of Cdc20 And Other APC/C:Cdh1 Targeted Proteins In Late Mitosis/early G1 Pathway Diagram
AUF1 (hnRNP D0) Destabilizes MRNA Pathway antibodies	AUF1 (hnRNP D0) Destabilizes MRNA Pathway Diagram
AXIN Missense Mutants Destabilize The Destruction Complex Pathway antibodies	AXIN Missense Mutants Destabilize The Destruction Complex Pathway Diagram
AXIN Mutants Destabilize The Destruction Complex, Activating WNT Signaling Pathway antibodies	AXIN Mutants Destabilize The Destruction Complex, Activating WNT Signaling Pathway Diagram

Diseases associated with anti-PSMD10 antibody

Disease Name	Pubmed Publications
Carcinoma Antibodies	>41 publications with PSMD10 and Carcinoma
Carcinoma, Hepatocellular Antibodies	>31 publications with PSMD10 and Carcinoma, Hepatocellular
Liver Diseases Antibodies	>29 publications with PSMD10 and Liver Diseases
Liver Neoplasms Antibodies	>28 publications with PSMD10 and Liver Neoplasms
Adenocarcinoma Antibodies	>21 publications with PSMD10 and Adenocarcinoma
Neoplasm Metastasis Antibodies	>13 publications with PSMD10 and Neoplasm Metastasis
Neoplasms, Experimental Antibodies	>6 publications with PSMD10 and Neoplasms, Experimental
Cell Transformation, Neoplastic Antibodies	>6 publications with PSMD10 and Cell Transformation, Neoplastic
Liver Neoplasms, Experimental Antibodies	>5 publications with PSMD10 and Liver Neoplasms, Experimental
Lung Neoplasms Antibodies	>5 publications with PSMD10 and Lung Neoplasms

Organs/Tissues associated with anti-PSMD10 antibody

Organ/Tissue Name	Pubmed Publications
Liver Antibodies	>36 publications with PSMD10 and Liver
Lung Antibodies	>5 publications with PSMD10 and Lung
Lymph Node Antibodies	>4 publications with PSMD10 and Lymph Node
Lymph Antibodies	>4 publications with PSMD10 and Lymph
Stomach Antibodies	>3 publications with PSMD10 and Stomach
Skin Antibodies	>3 publications with PSMD10 and Skin
Vascular Antibodies	>3 publications with PSMD10 and Vascular
Brain Antibodies	>3 publications with PSMD10 and Brain
Heart Antibodies	>2 publications with PSMD10 and Heart
Mouth Antibodies	>2 publications with PSMD10 and Mouth